Uncertainty Quantification for Machine Learning in Healthcare: A Survey
Authors:
L. Julián Lechuga López,
Shaza Elsharief,
Dhiyaa Al Jorf,
Firas Darwish,
Congbo Ma,
Farah E. Shamout
Abstract:
Uncertainty Quantification (UQ) is pivotal in enhancing the robustness, reliability, and interpretability of Machine Learning (ML) systems for healthcare, optimizing resources and improving patient care. Despite the emergence of ML-based clinical decision support tools, the lack of principled quantification of uncertainty in ML models remains a major challenge. Current reviews have a narrow focus…
▽ More
Uncertainty Quantification (UQ) is pivotal in enhancing the robustness, reliability, and interpretability of Machine Learning (ML) systems for healthcare, optimizing resources and improving patient care. Despite the emergence of ML-based clinical decision support tools, the lack of principled quantification of uncertainty in ML models remains a major challenge. Current reviews have a narrow focus on analyzing the state-of-the-art UQ in specific healthcare domains without systematically evaluating method efficacy across different stages of model development, and despite a growing body of research, its implementation in healthcare applications remains limited. Therefore, in this survey, we provide a comprehensive analysis of current UQ in healthcare, offering an informed framework that highlights how different methods can be integrated into each stage of the ML pipeline including data processing, training and evaluation. We also highlight the most popular methods used in healthcare and novel approaches from other domains that hold potential for future adoption in the medical context. We expect this study will provide a clear overview of the challenges and opportunities of implementing UQ in the ML pipeline for healthcare, guiding researchers and practitioners in selecting suitable techniques to enhance the reliability, safety and trust from patients and clinicians on ML-driven healthcare solutions.
△ Less
Submitted 4 May, 2025;
originally announced May 2025.
Detecting Glioma, Meningioma, and Pituitary Tumors, and Normal Brain Tissues based on Yolov11 and Yolov8 Deep Learning Models
Authors:
Ahmed M. Taha,
Salah A. Aly,
Mohamed F. Darwish
Abstract:
Accurate and quick diagnosis of normal brain tissue Glioma, Meningioma, and Pituitary Tumors is crucial for optimal treatment planning and improved medical results. Magnetic Resonance Imaging (MRI) is widely used as a non-invasive diagnostic tool for detecting brain abnormalities, including tumors. However, manual interpretation of MRI scans is often time-consuming, prone to human error, and depen…
▽ More
Accurate and quick diagnosis of normal brain tissue Glioma, Meningioma, and Pituitary Tumors is crucial for optimal treatment planning and improved medical results. Magnetic Resonance Imaging (MRI) is widely used as a non-invasive diagnostic tool for detecting brain abnormalities, including tumors. However, manual interpretation of MRI scans is often time-consuming, prone to human error, and dependent on highly specialized expertise. This paper proposes an advanced AI-driven technique to detecting glioma, meningioma, and pituitary brain tumors using YoloV11 and YoloV8 deep learning models.
Methods: Using a transfer learning-based fine-tuning approach, we integrate cutting-edge deep learning techniques with medical imaging to classify brain tumors into four categories: No-Tumor, Glioma, Meningioma, and Pituitary Tumors.
Results: The study utilizes the publicly accessible CE-MRI Figshare dataset and involves fine-tuning pre-trained models YoloV8 and YoloV11 of 99.49% and 99.56% accuracies; and customized CNN accuracy of 96.98%. The results validate the potential of CNNs in achieving high precision in brain tumor detection and classification, highlighting their transformative role in medical imaging and diagnostics.
△ Less
Submitted 31 March, 2025;
originally announced April 2025.
